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Background: Screening for bowel cancer using the guaiac faecal occult blood test offered by the NHS Bowel Cancer Screening
Programme (BCSP) is taken up by 54% of the eligible population. Uptake ranges from 35% in the most to 61% in the least deprived
areas. This study explores reasons for non-uptake of bowel cancer screening, and examines reasons for subsequent uptake among
participants who had initially not taken part in screening.
Methods: Focus groups with a socio-economically diverse sample of participants were used to explore participants’ experience of
invitation to and non-uptake of bowel cancer screening.
Results: Participants described sampling faeces and storing faecal samples as broaching a cultural taboo, and causing shame.
Completion of the test kit within the home rather than a formal health setting was considered unsettling and reduced perceived
importance. Not knowing screening results was reported to be preferable to the implications of a positive screening result.
Feeling well was associated with low perceived relevance of screening. Talking about bowel cancer screening with family and
peers emerged as the key to subsequent participation in screening.
Conclusions: Initiatives to normalise discussion about bowel cancer screening, to link the BCSP to general practice, and to simplify
the test itself may lead to increased uptake across all social groups.
Regular screening using the guaiac faecal occult blood test (gFOBt)
reduces the risk of dying from bowel cancer by 16% (Hardcastle
et al, 1996; Hewitson et al, 2008). Established in 2006, the English
NHS Bowel Cancer Screening Programme (BCSP) initially offered
biennial screening by gFOBt to all adults aged 60–69. Since 2010,
screening began to be extended to those aged up to 74. An analysis
of uptake of the first 2.6 million screening invitations found overall
uptake levels of 54% (von Wagner et al, 2011). This compares with
overall uptake rates of 73% in the longer established NHS Breast
Cancer Screening Programme (Health and Social Care Information
Centre, 2013) and 79% in the NHS Cervical Cancer Screening
Programme (Health and Social Care Information Centre, 2012).
Furthermore, a socio-economic gradient in gFOBt uptake exists
which ranges from 35% in the most deprived areas to 61% in the
least deprived areas (von Wagner et al, 2011).
Differences in uptake between socio-economic groups exist in
other areas of health care and screening programmes (Goddard
and Smith, 2001) but bowel cancer screening using gFOBt differs
from the other NHS Cancer Screening Programmes in that it is
self-completed. Eligible people receive a cardboard test kit through
the post which is completed with smears of faeces taken from three
separate bowel movements. The gFOBt is returned to the
laboratory by post and participants receive the result within 2
weeks (Halloran, 2009). Studies primarily conducted in the United
States report that reasons for not completing the gFOBt include
feeling healthy, having no bowel symptoms, fear of the results of
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the screening test, and ‘not wanting to know’ (the latter often
linked to doubts about the value of screening for the detection of
health problems) (Beeker et al, 2000; McCaffery et al, 2001;
Weitzman et al, 2001; Clavarino et al, 2004; Wackerbarth et al,
2005; Aubin-Auger et al, 2011). Difficulties in understanding the
kit instructions, concerns about hygiene and storage of the kit,
avoiding or delaying decision making, intention to take part but
failure to do so for practical reasons, and a preference for a doctor
to do such tests have also been identified as reasons for not
completing screening (Dent et al, 1983; Szczepura et al, 2003;
O’Sullivan and Orbell, 2004; Chapple et al, 2008; Hall et al, 2013).
Of the four studies undertaken in the United Kingdom, two were
conducted with individuals before being invited to be screened.
Thus, they reported participants’ beliefs about how they might
behave rather than explanations based on actual experience
(Szczepura et al, 2003; O’Sullivan and Orbell, 2004). The other
two UK studies reported the views of participants who had been
invited to participate in the NHS BCSP; in one, the majority of
these participants had completed the gFOBt kit (Chapple et al,
2008), and the other reports on a relatively small sample restricted
to one regional area (Hall et al, 2013).
We therefore have little understanding of the reasons for low
uptake overall and for the social gradient in uptake of gFOBt in the
English NHS BCSP. Furthermore, the NHS BCSP re-invites eligible
adults every 2 years irrespective of whether or not they have
previously responded and previous research has identified that
repeated invitations increase uptake (Steele et al, 2010). Exploring
reasons for subsequent participation among those who did not
initially take up the screening invitation provides the unique
opportunity to identify the tipping point to participation in
screening and could inform interventions to address perceived
barriers at the time of the first invitation. We therefore explored
reasons for non-uptake of gFOBt among participants from diverse
socio-economic backgrounds who had not accepted at least one
screening invitation, and explored reasons for subsequent partici-
pation among participants who had not completed the gFOBt at an
earlier invitation.
MATERIALS AND METHODS
Recruitment and sampling. The BCSP is delivered through five
regional hubs in England. To recruit a socio-economically diverse
range of participants, we used Index of Material Deprivation
(IMD2010) scores to identify areas of South Yorkshire and London
that embodied a spread of IMD scores, from the most to the least
deprived. This index is a widely used area-based measure that
combines seven domains (covering income deprivation, employ-
ment deprivation, health deprivation and disability, education
skills and training deprivation, barriers to housing and services,
living environment deprivation, and crime), into a single
deprivation score for a small area (Department for Communities
and Local Government, 2011). In collaboration with the two BCSP
hubs covering South Yorkshire and London, 5100 individuals
residing in areas including the most and least deprived as defined
by IMD2010 who were recorded as having not accepted the
invitation to screen on at least one occasion were invited to take
part in a focus group held locally. Focus groups are of particular
value when exploring reasons why people choose not to do
something, or what Barbour terms ‘why not’ questions (Barbour,
2010). Respondents were allocated to one of sixteen focus groups
(eight in Yorkshire and eight in London). Previous research found
that focus groups benefit from being organised around the
homogeneity of the participants (Bloor et al, 2001). Therefore,
previous/current occupation has been used as a pragmatic
indicator of socio-economic circumstances to allocate participants
into groups with others of similar occupational and therefore
socio-economic backgrounds (Craig and Forbes, 2005). Due to the
potentially sensitive nature of the research topic, we also
established separate focus groups for men and women.
In addition to participants who were recruited directly through
the BCSP, and to more fully reflect the socio-demographic
characteristics of the eligible screening population we also
opportunistically recruited people of African-Caribbean origin
through community settings in London. The use of an opportu-
nistic approach was informed by previous studies which found that
to explore Black and Minority Ethnic participants’ experiences of
health and health services may require alternative recruitment
strategies to those used to recruit white European origin
participants (McLean and Campbell, 2003; Twamley et al, 2010).
An earlier study identified specific concerns about flexible
sigmoidoscopy screening methodology held by men of African-
Caribbean origin (McCaffery et al, 2001). We therefore sought to
explore whether there were views and experiences of bowel cancer
screening by gFOBt that were specific to this group. We held two
focus groups, one with men and one with women of African-
Caribbean ethnicity organised without reference to the occupa-
tional background of participants.
Data collection. Data were generated during 18 focus groups
undertaken between July 2011 and April 2012. A topic guide was
used to ensure that key topics were covered in each focus group.
Groups were audio recorded and transcribed verbatim.
Analysis. Data were analysed inductively using techniques
originating in grounded theory to generate themes from the data
(Glaser and Strauss, 1967). Grounded theory describes an inductive
approach to analysis in which data are used to derive and generate
theory, in contrast to a deductive approach in which data are
generated to test out a pre-existing theory (Murphy et al, 1998). By
repeated close reading, and constant comparison of data, two
researchers descriptively coded data as it was generated. Coded
data were categorised into areas of thematic relevance to the
research objectives. Through this iterative process and accompa-
nied by discussion and writing, key themes were developed and
refined, and links drawn between them. Comparative analyses were
undertaken to determine whether themes specific to participants
with non-professional compared with professional backgrounds
(i.e., as an indicator of socio-economic difference) could be
identified.
Ethics. The study received ethical approval from South East
London research ethics committee five (reference 11/H0805/7),
and NHS trust research governance was obtained at the relevant
sites. Written informed consent was obtained from all participants.
RESULTS
Participant characteristics. In all, 243 individuals returned a
completed consent form indicating willingness to take part in the
research, of whom 128 subsequently took part in a focus group.
The research team paid attention to ensure the sample included a
balance of men (n¼ 67) and women (n¼ 61), and individuals with
reported professional (n¼ 61) and non-professional (n¼ 50)
occupational backgrounds (Table 1). Reported professional
occupations included teacher, local government officer, solicitor,
civil servant, nurse, dentist, journalist, artist, and social worker; and
non-professional occupations included sales assistant, cook,
cleaner, carer, builder, miner, driver, waitress, postman, and
carpenter. In common with the purposively sampled focus groups,
the opportunistically recruited focus groups comprising individuals
of African-Caribbean origin included participants who had and
had not taken part in bowel cancer screening. The majority of
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participants recalled receiving invitation(s) and gFOBt kit(s) from
the BCSP. One hundred participants reported gFOBt non-uptake
on at least one occasion, of whom 31 went on to complete the
gFOBt kit when they were invited to take part in a subsequent
screening round. Nine participants had not completed the gFOBt
due to ‘alternative uptake’ of bowel cancer screening, such as
colonoscopy, endoscopy, or gFOBt kit completion in primary or
private care.
Our comparative analyses found high levels of consistency in
accounts for non-uptake regardless of gender, ethnicity, or
geographical location.
Themes. We present our findings as a series of six themes
described below.
Themes common across non-professional and professional
occupational groups:
Risks posed by faeces. Participants in all focus groups explained
their aversion to complete a gFOBt kit by reference to the perceived
risks that collecting, storing, and posting samples of faeces posed to
hygiene. These risks were heightened by the requirement to
complete the kit with samples from three separate bowel move-
ments, which meant that the kit had to be stored over several days.
Participants reported that the completion of the gFOBt kit
threatened to physically pollute them or their environment, and
that they would need to go to extreme lengths to manage these
perceived threats.
‘People’s hands have to handle this yes? You don’t know how
strong germs getyso I don’t fancy it going through the post.’
(FG17P1)
‘It’s like sort of not flushing, only worse, it’s sort of not niceyI
wanted to scrub the bathroom down every day, so I thought it’s not
worth the hassle.’ (FG03P5)
Completion of the gFOBt was considered to pose serious and
fundamental threats to notions of socially acceptable and proper
behaviour. Participants reported discomfort at the idea of handling
faeces because this was an activity that was abnormal, broached a
cultural taboo or could cause embarrassment and shame.
‘You wouldn’t normally leave faeces in your bathroom for three
days.’ (FG07P3)
‘It’s just not the done thing is it?’
‘No – to mess about with it.’ (FG08P5þ 6)
‘What will happen in the bathroom with ityyou know the
whole complication of where to put it and if someone else walks in
and finds it.’ (FG16P4)
The perceived taboo of interacting with faeces was further
illustrated by participants’ concerns about being ‘found out’ to
have completed the gFOBt. Being found to have stored or posted
faecal samples was believed to be potentially socially and personally
damaging, in that it could reflect badly on the individual and
undermine them in the eyes of others. Some participants described
the requirements of the gFOBt as ‘offensive’ and ‘degrading’. The
use of the term ‘degradation’ is of particular significance, because it
carries ideas of personal cost in that it compromises the individual.
Thus, completing the kit raised the threat of being at best
embarrassed and at worst, disgraced and discredited.
‘Put your poo in the posty I thought oh god, y’know it’s got
your name on it and what if they open it.’ (FG15P5)
‘I’ve had two I’ve sent them both in the dustbin. I won’t discuss
it but I were a bit offended.’ (FG09P6)
‘I’ve had one and I ain’t done it, I just felt degraded to tell you
the truth.’ (FG11P5)
The aversion to dealing with faeces that emerged in participants’
accounts of non-uptake is underpinned by deeply ingrained
definitions of faeces as a taboo substance (Thompson, 2013),
Table 1. Focus group composition
Location
No. of
participants
Occupational background
as indicator of
socio-economic circumstance Sex Ethnicity of participants
FG01 London 11 Professional M All White European
FG02 London 5 Non-professional M All White European
FG03 London 8 Professional F 7 White European, 1 South Asian
FG04 London 6 Non-professional F 5 White European, 1 African Caribbean
FG05 South Yorkshire 7 Professional M All White European
FG06 South Yorkshire 8 Non-professional M All White European
FG07 South Yorkshire 7 Professional F All White European
FG08 South Yorkshire 6 Non-professional F All White European
FG09 South Yorkshire 7 Non-professional M All White European
FG10 South Yorkshire 8 Professional M All White European
FG11 South Yorkshire 6 Non-professional F All White European
FG12 South Yorkshire 6 Professional F All White European
FG13 London 6 Non-professional M All White European
FG14 London 8 Professional M 7 White European, 1 West African
FG15 London 6 Non-professional F 4 White European, 2 African Caribbean
FG16 London 6 Professional F All White European
FG17 London 10 Not recorded F 9 African Caribbean, 1 South Asian
FG18 London 7 Not recorded M 6 African Caribbean, 1 West African
Screening non-uptake within the NHS BCSP BRITISH JOURNAL OF CANCER
www.bjcancer.com |DOI:10.1038/bjc.2014.125 1707
and rigid social rules surrounding how it is appropriately
dealt with.
Detachment from familiar health-care settings. Participants
reported discomfort with the detachment of gFOB testing from
‘usual’ health-care settings and professionals. They expressed a
preference to attend a health setting such as a GP surgery or
hospital and for ‘someone else’ to undertake the screening on their
behalf.
‘Why don’t they send you t’doctors or hospital to have it done
there?...if the doctor sent for me and said I want to do so and so for
you I’d go, or the hospital but doing that meself, I didn’t like it at
all.’ (FG09P6)
On one level, participants linked their desire to ‘go somewhere’
such as a GP surgery or hospital with the avoidance of having to
collect and sample their faeces. However, participants’ references
to medical settings as ‘preferred’ also revealed that the invitation
to the BCSP was out of context and unsettling, because it
required them to undertake a health procedure outside the settings
in which health care is usually practiced. Further, linked to
this was a perception of ‘self-testing’ as unusual and unexpected,
particularly by comparison with other screening experiences
or medical interactions where ‘a professional’ is involved in the
procedure.
‘I thought ‘oh my god now we are asked to be doctors’.’
(FG16P6)
‘I threw mine away, I’d rather have it done for me.’
‘I’d rather go somewhere and have it done to be quite honest.’
(FG04P5þ 6)
Participants emphasised that it was unusual to have an active
role in a health procedure, when the norm in medical encounters
was for them to be the passive ‘receiver’ of care. They also disliked
the impersonal nature of home testing:
‘I would prefer my doctor to have some obvious interaction with
me in the actual process rather than it being done with an
anonymous third party.’ (FG01P8)
By extension, it was noteworthy how many participants claimed
that, had they been given an appointment to attend, or been told by
their GP to complete a gFOBt kit, they would have done so. It
appeared therefore that the detachment from clinical settings and
professional roles may have reduced the perceived importance of
the offer of screening.
‘The message that was communicated to me was that this was
hardly urgent or serious because if it was they would send me off to
have a clinician do it.’ (FG01P1)
‘If the letter had come from my GPyI would have taken it
more seriously.’ (FG18P6)
The prospect of self-testing at home therefore inhibited rather
than facilitated uptake.
The implications of knowing the screening results. The most
complex theme to emerge related to the implications of knowing
the screening results. Participants preferred not to be in possession
of this information for several reasons. First, they commonly
referred to the undesirable implications of a positive result. Thus,
they expressed unwillingness to undergo the recommended
procedures that may follow a positive gFOBt result, such as
colonoscopy or bowel surgery. These participants often referred to
previous experiences (their own or family members’) of bowel
investigations or treatment for gastroenterological problems, and
described their negative consequences.
‘It’s the after effects, if they do find something, that would put
me off taking the test in the first placeyit’s the colonoscopy, the
treatment of the colonoscopy.’ (FG10P3)
Non-uptake was therefore a means to protect oneself from the
possible unpleasant consequences of a positive test.
Second, participants distinguished between ‘being unwell’ and
‘knowing about being unwell’. A positive screening result meant
that they would need to ‘redefine’ themselves as being unwell,
which they did not wish to do because they believed it was
unnecessary.
‘If there’s something the matter with me now, and I don’t
know about it, I’m fine. If somebody says I’ve got a problem,
I’m going to worry about it, and I don’t want that, you know
you live life as it is now and I don’t want people finding things.’
(FG10P6)
Thus, there emerged from participants’ accounts an alternative
reading of screening as an activity that, rather than maintaining
good health, may actually be complicit in generating ill health.
By presenting screening as a process that could undermine health,
and questioning the value of the knowledge offered by screening to
the maintenance of good health, participants pointed out that the
benefit of declining to complete the gFOBt allowed one to ‘get on
with life’.
‘This is just like sticking your head down the loo and thinking
you’ve got cancer all day, you know there’s a balance of how much
‘into’ things you should get.’ (FG03P3)
‘To me it’s like mollycoddling yourself so everything working
right, don’t mess about with yourself.’ (FG05P1)
Finally, the possibility that screening might identify cancer and
result in subsequent interventions was described by some
participants as too frightening to contemplate. The knowledge
offered by screening was for some a stressful and frightening
prospect, to the extent that actively choosing not to be in
possession of this information was preferable.
‘I’m scared, simple as thatyit’s the test coming back positive
that worries me, so I tend to ignore it and hope it goes away.’
(FG02P2)
Researcher: ‘What’s frightening?’
Participant: ‘What actually might be discovered, what I don’t
know is not there like, if you know what I mean.’ (FG13P3)
Thus, some participants demonstrated an ambivalence towards,
or overt rejection of the knowledge offered by screening. Analysis
of the accounts of participants who ‘didn’t want to know’ found
that it was also common for such participants to describe cancer as
a particularly serious and frightening diagnosis for which
treatment was unpleasant and often futile. Participants’ attitudes
towards cancer treatment further underpinned their rejection of
the knowledge offered by screening, because, if there was perceived
to be little benefit associated with treatment, there was little point
in taking part in screening.
‘[A friend] went through all that chemotherapy and all that
suffering it didn’t make aydifference.’ (FG08P6)
BRITISH JOURNAL OF CANCER Screening non-uptake within the NHS BCSP
1708 www.bjcancer.com |DOI:10.1038/bjc.2014.125
Judgements of good health and low relevance of screening. Many
participants believed that the gFOBt was irrelevant because they
were certain that they did not have and were unlikely to get bowel
cancer. The evidence they cited included a lack of symptoms, being
physically active and having no family history of bowel cancer.
‘I’ve got no symptoms so I’m alright, y’know, I go to the toilet
regular and y’know, I exercise and I’m fit.’ (FG09P1)
Descriptions of being in good health were often interwoven with
other themes of non-uptake.
Themes present among professional occupational groups only:
Delaying uptake, leading to non-uptake. No themes emerged
solely from participants with non-professional backgrounds.
However, we identified one theme associated with non-uptake
which was discussed only by participants with professional
backgrounds. These respondents commonly described their non-
uptake in terms of delay, rather than outright rejection.
Participants reported that the gFOBt was ‘put to one side’, or
‘put in the in-tray’ implying some degree of intention to
participate, but ultimately kits were not completed. Delay was
often linked to descriptions of the complexity of the instructions
for completing the gFOBt, and also the time-consuming nature of
kit completion.
‘You’ve got to really sit down and read it, y’can’t, it’s not just
something you can pick up and say ‘oh I’ll go and do that now’,
you’ve got to study it.’ (FG12P4)
‘It’s quite a long winded, drawn out thing I just kept putting off
doing it.’ (FG03P8)
There was a common misconception among participants in all
focus groups that samples had to be taken on 3 consecutive days.
Respondents from professional backgrounds cited this rigid, 3-day
‘window’ for test completion as a cause of delay and subsequent
non-completion because it was not possible to fit the test
requirements in with their bowel movements or routine and
lifestyle.
‘If I start it on one day I’ve got to remember then to do it for the
next two days and that was a big block for me because I’m very
rarely in the same place for three days in a row.’ (FG14P8)
Non-uptake followed by uptake in a subsequent screening
round:
The power of talk: a key ‘tipping point’. Participants from all
occupational backgrounds who reported that they had not initially
participated in screening and had then completed the gFOBt in a
subsequent screening round described being influenced by
discussions with family members, friends, and health professionals.
They reported being questioned about their initial refusal to
complete the test or being told outright to take part in bowel cancer
screening. They also recalled supportive discussions in which their
concerns about or aversions to the gFOBt kit were discussed and
challenged. Participants reported that becoming aware that their
partner or friends had already completed the gFOBt was
influential. In addition, they reported that becoming aware that a
family member or friend had developed bowel cancer influenced
them to take part in screening.
‘My brother in law was diagnosed with bowel cancer after I’d
had the first request which I totally ignoredymy wife did [her
gFOBt] and she got her results back which were clear, peace of
mind, I thought well you silly bugger, you know why didn’t I do
[it]?’ (FG09P4)
‘A friend also had it and she was telling me about how she did it
and I thought gosh it’s not as complex as I think.’ (FG16P2)
Discussions in which other individuals championed participa-
tion in screening, or revealed their own gFOBt uptake was
repeatedly implicated by participants as the key tipping point to a
decision to undertake screening on a subsequent occasion.
Through talk with others, participants described themselves as
‘nagged’, encouraged and reassured to undertake the gFOBt.
Furthermore, through talking with others, and becoming aware of
others’ completion of the gFOBt, uptake was repositioned as a
normal activity. The particular power of talk appeared to normalise
the unusual, unexpected and potentially taboo aspects of the
gFOBt kit.
‘I think as well it’s a critical mass isn’t it, so you discover your
friends are all doing it or whatever so then it does become a slightly
normal thing to do.’ (FG16P1)
DISCUSSION
Summary of principal findings. The multifaceted explanations
for non-uptake of gFOBt that we found do not, in the main, vary
according to individuals’ socioeconomic backgrounds. In addition
to practical objections (a perceived hygiene risk, complex or
unfeasible instructions and process), we demonstrate that gFOBt
completion posed threats to social self (by breaking social taboos
surrounding faeces that might bring embarrassment and shame on
the participant) (Lawton, 1998; Thompson, 2013). Furthermore, it
posed threats to participants’ wellbeing (e.g., by redefining well
people as ill, and leading to unwanted investigations). Self-testing
at home and beliefs about low personal risk of developing bowel
cancer undermined the value and relevance of screening. However,
talk increased awareness of screening uptake by peers and
significant others and was key to overcoming objections, and to
subsequent screening participation.
Comparison with other research. Our finding that non-uptake is
linked to detachment of gFOBt from clinical settings is a novel
finding, which has not to our knowledge been reported previously
in the United Kingdom. An Australian study from the 1980s
reported that some people declined doing a gFOBt because they
wanted their own doctors to do such tests (Dent et al, 1983). This
may explain why general practitioner endorsement of bowel cancer
screening invitation letters can increase screening uptake (Cole
et al, 2002; Hewitson et al, 2011). Previous studies report that
participants downplay concerns relating to handling faecal matter,
or frame such concerns solely in terms of hygiene risks (Weitzman
et al, 2001; O’Sullivan and Orbell, 2004; Chapple et al, 2008). We
demonstrate the greater complexity of this concern in terms of its
relationship to shame, embarrassment, and the broach of cultural
taboos. Our more extensive findings are likely to be explained by
our recruitment criteria that allowed us to explore reasons for non-
participation in screening among participants who had been
invited to the NHS BCSP on more than one occasion. In contrast,
although Chapple et al (2008) interviewed people who either
delayed or who had refused screening they also included many
people who took part in screening without delay. Other previous
studies included people who had not yet received a screening
invitation from the BCSP (Weitzman et al, 2001; O’Sullivan and
Orbell, 2004).
In common with previous research, we identified non-uptake as
preferable to being in possession of the information offered by
screening due to the potential negative implications of a positive
gFOBt result (McCaffery et al, 2001; Weitzman et al, 2001;
O’Sullivan and Orbell, 2004; Chapple et al, 2008). Previous studies
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have also documented the belief that screening is unnecessary for
asymptomatic, fit individuals with no family history (Beeker et al,
2000; McCaffery et al, 2001; Clavarino et al, 2004; Chapple et al,
2008). The inconvenience of gFOBt completion and mistaken
belief that samples had to be collected on 3 consecutive days has
also been reported previously (Beeker et al, 2000; Chapple et al,
2008). Finally, previous research highlights the difficulties of
talking openly about bowel cancer (Beeker et al, 2000; Szczepura
et al, 2003; O’Sullivan and Orbell, 2004). However, our finding
about the impact of talk with others on subsequent screening
uptake resonates with the proposal in Beeker et al (2000), that
greater cultural visibility of colorectal cancer screening, for
example in the mass media, may provide people with the
‘‘permission,’ motivation and the tools’ to discuss this culturally
taboo topic and to normalise test completion as an everyday
activity.
These qualitative data illustrate how core beliefs described in
health behaviour models (e.g., the Health Belief Model; Rosenstock,
1974) manifest themselves in the context of bowel screening. First,
issues around faecal sampling represented an important emotional
barrier to bowel screening. Second, the importance of perceived
susceptibility in cancer screening was illustrated by the theme that
screening is not relevant among those who regard themselves as
healthy. Finally, the power of talk highlights the importance of
providing external (social) cues to action in addition to routine
invitations and reminders. Specifying core beliefs is instrumental in
developing theory-based interventions to increase uptake.
Strengths and limitations. This is the largest in-depth exploration
of non-uptake of bowel cancer screening and the first study to
explore why non-participants subsequently undergo screening.
Knowledge about the determinants of behaviour changes provides
foci for the content of strategies to increase uptake. However, we
were unable to delineate specific reasons for lower uptake among
more socially disadvantaged groups. This may be in part because of
the existence of a social gradient in uptake rather than a gap
between two discrete social groups for whom there may be distinct
explanations for their behaviour. It may also have been in part due
to our inability to explore a potential link between literacy levels
and uptake. Finally, because our sample did not include people
with chronic illnesses we could not explore the role of poor health
(and associated functional impairments) in uptake.
Implications for UK policy and practice. Our results suggest that
strategies to increase gFOBt uptake in all social groups should
include three components. First, initiatives to normalise open
discussions about bowel cancer screening should be designed and
evaluated, such as the advertising campaign on-going in Greater
Manchester to encourage people to talk about the BCSP (Greater
Manchester Bowel Cancer Screening Health Improvement Team,
2012). Second, there should be explicit linkage of the BCSP to
general practice. Endorsement of invitation, letters either by the
medical practice or by an individual general practitioner is known
to be effective (Cole et al, 2002; Hewitson et al, 2011). We are
currently experimentally evaluating an amendment to the BCSP
invitation letter which simply states that the individual’s named
general practice endorses the invitation, and some areas are using
financial incentives to encourage GPs to follow-up patients who
have not accepted a screening invitation. Third, existing informa-
tion materials require amendment to clarify the advantages of early
diagnosis in asymptomatic individuals. In addition, the single-
sample faecal immunochemical test (FIT) is due to be piloted
within the BCSP in 2014. If effective, then it should address
obstacles associated with the complexity and storage of the current
gFOBt. The relationship between literacy and uptake requires
further exploration through the experimental comparison of new
information designed to address readability and comprehension in
comparison with existing BCSP materials.
It is noteworthy that while our study identifies reasons for non-
uptake specific to bowel cancer screening, it also reports reasons
for non-uptake (implications of knowing screening results;
judgements of good health; low relevance of screening), which
could be considered more generic and relevant to other screening
programmes.
CONCLUSIONS
Explanations for non-uptake of the gFOBt do not, in the main,
vary according to individuals’ socioeconomic backgrounds.
Strategies to improve uptake of bowel cancer screening should
incorporate initiatives to normalise open discussion about bowel
cancer screening; explicitly link the BCSP to general practice;
modify existing BCSP materials to state the advantages (and risks)
of early diagnosis in asymptomatic individuals; and simplify the
screening test itself.
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